Promarker™Endo
Endometriosis
Late‑stage validationActive
Key Facts
About Proteomics International
Australian proteomics company delivering early‑detection blood tests for kidney, cancer and gynecologic diseases.
View full company profileTherapeutic Areas
Other Endometriosis Drugs
| Drug | Company | Phase |
|---|---|---|
| EV‑Endo | Cartherics | Preclinical |
| Endometriosis Program | Cyclana Bio | Discovery |
| Endometriosis Genetic Study | Juneau Biosciences | Discovery |
| Potential Diagnostic Development | Juneau Biosciences | Research |
| Endometriosis Discovery Program | Metri Bio | Discovery |
| Endometriosis Test Suite | Heranova Lifesciences | Pre-clinical |
| EndomTest | Kephera Diagnostics | Commercial (LDT) |
| ENDO-205 | EndoCyclic Therapeutics | Phase 1 |
| Undisclosed Immunotherapy | Apheon Bioscience | Preclinical |
| FMC | FimmCyte | Pre-clinical |
| ABC-201 | Abcely | Preclinical |
| ERβ Modulator Program | Cadenza Bio | Preclinical |